Cephalon's Frank Baldino - CEO Pay
Frank Baldino - Cephalon
Total Compensation: $14.5M
Details: In 2007, with an overall salary of $13.5 million, Baldino managed to pull down $2 million more than the previous year. The CEO--who's paid much more than those in his peer group--didn't manage such a hefty salary jump in 2008. With his total compensation rounding out to $14.5 million, Baldino's 2008 raise came in at just under $1 million last year. His salary included $63,750 for personal use of the company car, insurance, financial planning and medical reimbursements.
Cephalon News:
Cephalon hikes prices to fight generic
Cephalon finalizes $425M off-label settlement
FDA approves Cephalon's Treanda
FDA panel rejects broader Fentora use
FTC sues Cephalon for blocking generics
Cephalon, NitroMed make cuts jobs
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: